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Neopterin. a pyrazino-pyrimidine derivattve. IS synthesized m excess by human monocytes/macrophages upon stimulation with interferon-y, a 
cytokine derived from activated T-cells Neopterm is furthermore produced constitutively. A relatively constant ratio between neopterin and its 
reduced form, 7Sdihydroneopterin has been described in human serum. In the study presented here we tested the ability of neopterin and its 
reduced form to modulate the effects of cytotoxtc substances like hydrogen peroxide or hypochlorous acid and N-chloramme derivatives. We show 
that 7,Gdihydroneopterin potently reduces biological and chemical effects of these substances independently from the pH value. In contrast, at 
slightly alkaline pH (pH 7 5) neopterin enhances hydrogen peroxide and chloramine-T activity. This is demonstrated by increase of signal intensity 
in a luminol assay and also by enhancement of toxicity towards bacteria. Thus, the macrophage derived substance neopterin is able both to enhance 
and to reduce cytotoxicity m dependence of pH value and its oxidation state, and it may have a pivotal role in modulation of macrophage mediated 
effector mechanism. 
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1. INTRODUCTION 
The macrophage is a central effector cell of the cellu- 
lar immune response. When stimulated by cytokines 
derived from activated T-cells such as, e.g. interferon-y, 
macrophages produce, besides a lot of other secretory 
products, reactive metabolites of oxygen such as hydro- 
gen peroxide, superoxide and hydroxyl radicals [l]. 
Hydrogen peroxide is a central molecule in mediating 
macrophage and granulocyte mediated extracellular cy- 
tolysis [2]. Upon stimulation. monocytes further release 
myeloperoxidase which reacts with hydrogen peroxide 
and chloride to form hypochlorous acid and chloram- 
ines. These components have turned out to be highly 
toxic to ingested microorganisms [3,4]. Upon stimula- 
tion by interferon-y, macrophages further produce and 
release large amounts of neopterin [5]. and concentra- 
tions up to 1 pmolll have been measured locally in 
humans [6]. Neopterin derives from 7,8-dihydroneop- 
terin triphosphate, the first intermediate in the biosyn- 
thesis of tetrahydrobiopterin from GTP. Since human 
macrophages contain a particularly low activity of 6- 
pyruvoyl tetrahydropterin synthase, the second enzyme 
of the pathway, only a minor of the accumulated 7.8- 
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dihydroneopterin triphosphate is further metabolized to 
tetrahydrobiopterin, whereas the major part is cleaved 
by phosphatases to 7&dihydroneopterin [7]. This is 
then partially oxidized to neopterin and a nearly con- 
stant ratio neopterin to dihydroneopterin of about 1:2 
has been observed in serum of healthy individuals, cor- 
responding to median concentrations of 4.7 nmol/l ne- 
opterin and 8.9 nmol/l 7,%dihydroneopterin [8]. Al- 
though neopterin has turned out as a clinically useful 
marker for monitoring patients with activated cellular 
immunity [9], e.g. elevated neopterin levels were ob- 
served in subjects suffering from viral infections like 
hepatitis or HIV-infection, malignancies, autoimmune 
disorders or during allograft rejection [lo-141, no bio- 
logical role could be established so far for this sub- 
stance. 
Neopterin is furthermore produced constitutively, 
and most recently significantly higher concentrations of 
7&dihydroneopterin were observed in arterial as com- 
pared to venous blood [15]. This finding suggests that 
these alterations of neopterin levels may be due to proc- 
esses occurring in the peripheral capillary system. Since 
neither neopterin nor 7.8-dihydroneopterin did exert an 
effect on the binding of oxygen to hemoglobin, the up- 
take of carbon dioxide by erythrocytes, or the activity 
of enzymes such as peroxidase (Weiss, G. et al., unpub- 
lished observations). we tested whether neopterin and 
7,8_dihydroneopterin may influence effects of hydrogen 
peroxide, hypochlorous acid and chloramines. 
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2. MATERIALS AND METHODS 
2.1. Luminol-dependem measurement of chemilumrnescence 
Neopterin, 7,8dihydroneopterin and 5,6,7,8tetrahydroneopterin 
(Schncks Lab., Jona, Switzerland) were dtssolved in phosphate-buff- 
ered salme which was previously adjusted to pH between 5.5 and 7.5. 
Luminol (5-amino-2,3-dihydro-1,4-phthalazinedtone obtained from 
Sigma. Mumch, Germany) was dissolved in DMSO at a final concen- 
tration of 10 mM and a 40pM working solution was freshly prepared 
by dilution with phosphate-buffered saline, pH 7.5. 150 ~1 of luminol 
solution and 750~1 of phosphate-buffered sahne with/without variable 
amounts of ptertdines were incubated in microcuvettes at 37°C in a 
luminometer (LKB 1251, Pharmacta, Piscataway, NJ). 200 ,ul of 1% 
hydrogen peroxide (0.29 M) or 0.05% chloramine-T (1.77 mM) solu- 
tion were injected and light output was measured for 30 s at 37°C. 
Maximum light output of samples was compared to that of control 
(phosphate buffered saline, luminol. chloramine-T or hydrogen perox- 
ide). Plots show mean values (mean f S.E.M.) for four independent 
expertments performed in duplicate. 
2.2. Quuntlficatron of antimicrobial toxicit? 
Bacteria of the strains Escherichia coli and Staphylococcus aureus 
were grown in Nutrient Broth No. 2 medium (Oxoid Ltd., Hants, UK) 
for 24 h. 200 ~1 of this suspension of exponenttally growmg bacteria 
were diluted m 50 ml of fresh culture medium. One ml was transferred 
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to sterile cuvettes contaming 1 ml of phosphate-buffered saline (pH 
7.5) with/without neopterin or 7&dihydroneopterin (final concentra- 
tion 200pM). Then 1 ml 0.25% (8.9 mM) chloramine-T was added and 
cytotoxictty towards bacteria was measured by poured plate tech- 
nique. This was carried out by transferring 500 ~1 of bacteria/phos- 
phate-buffered saline with/without neopterin or 7&dihydroneopterm/ 
chloramme-T suspension to a sterrlized plate and further addition of 
10 ml of molten nutrient agar All plates were incubated for 24 h at 
37°C. 
3. RESULTS AND DISCUSSION 
As pointed out in Fig. 1,7,8-dihydroneopterin as well 
as 5,6,7&tetrahydroneopterin drastically reduce maxi- 
mum chloramine-T, a disinfectant dissociating in aque- 
ous solution into hypochloric acid and various N-chlo- 
ramines (161, and hydrogen peroxide-induced chemolu- 
minescence in a luminol assay. The reduction occurred 
in a dose-response relationship and was almost un- 
changed within the pH range tested (from pH 5.5 to 
7.5). 7,8-Dihydroneopterin and 5,6,7&tetrahydroneop- 
terin are almost equal in their scavenging activity. 
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Fig. 1. Effects of pteridines on hydrogen peroxide- and chloramine-T-induced chemoluminescence in dependence on pH-value. The upper panel 
shows effects of increasing concentrations of neopterin (N), 7,8_dthydroneopterin (NH’), and 5,6,7,8_tetrahydroneopterm (NH4) on hydrogen 
peroxide-induced luminol-dependent chemolummescence. Light output after additron of hydrogen peroxtde (final concentration 53 mM) to luminol 
and phosphate buffered sahne solution was used as control. The peak value of light output of the control was set equal to 100% and compared 
with peak values of the samples investigated. Since m all experiments the results obtained at pH 5.5 and pH 6.5 were not stgmficantly dtfferent. 
only results obtained at pH 5.5 are shown. The lower panel outlines the results for the corresponding experiments performed with chloramme-T 
(final concentration 320 PM). 
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Fig. 2. Time course of lummol-dependent chemoluminescence in the presence of reactive molecules and pteridines at pH 7.5. Oxidant concentrations 
were the same as described in the legend to Fig. 1. 
In contrast, neopterin did not significantly alter chlo- 
ramine-T or hydrogen peroxide induced signal intensity 
at slightly acidic pH (5.5 and 6.5), but had an exorbi- 
tantly enhancing effect on chemoluminescence at pH 
7.5, also following a dose-response relationship (Fig. 1). 
Fig. 2 outlines the time course of luminol-dependent 
chemoluminescence. In the presence of a medium neop- 
terin concentration (2 ,uM) a sharp increase of hydrogen 
peroxide (left) as well as chloramine-T (right)-induced 
signal intensity occurs (Fig. 2). This multiplication of 
light output is not delayed in time as compared with the 
control (hydrogen peroxide or chloramine-T alone), is 
observed immediately after addition of chloramine-T/ 
hydrogen peroxide and therefore does not seem to be 
due to, e.g. time-dependent accumulation of reactive 
molecules in the presence of neopterin. This suggests 
that neopterin may enhance formation of reactive mol- 
ecules originating from chloramine-T or hydrogen per- 
oxide or, that neopterin itself may be converted into a 
reactive intermediate upon reaction with hydrogen per- 
oxide and chloramine-T. On the other hand, 7,8-dihy- 
droneopterin and 5,6,7,8_tetrahydroneopterin reduce 
signal intensity as compared with the control (Fig. 2). 
This is likely due to effective scavenging of reactive 
molecules derived from hydrogen peroxide or chloram- 
ine-T. It can be further seen that neopterin, 7,8-dihy- 
droneopterin and 5,6,7,8_tetrahydroneopterin per se do 
not cause any change of luminol-dependent chemolu- 
minescence since basic levels (at time 0, i.e. before injec- 
tion of chloramine-T or hydrogen peroxide) are not 
different from the control, i.e. luminol and phosphate- 
buffered saline, pH 7.5. 
We then tested if the pteridine-mediated modulation 
of chemoluminescence may influence toxicity of hydro- 
gen peroxide or chloramine-T against microorganisms. 
Fig. 3 depicts the results of a typical pouring plate ex- 
periment performed with E. coli bacteria in the presence 
of chloramine-T and/or neopterin or 7,8-dihydroneop- 
Fig. 3. Alteration of chloramine-T-induced toxicity towards mtcroorganisms by neopterin and 7,Gdihydroneopterin as tested by survival of E. coli. 
After addition of pteridines and chloramme-T bacterta were incubated at 37°C for 30 min. Pouring plate technique was used for quantification 
of bacteria survival. C, control (bacterta, chloramme-T. phosphate-buffered saline. pH 7.5); N, control plus neopterm; NH2. control plus 
7,Gdthydroneopterin. For detatls see sectton 2. 
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terin. From these data it is evident that exposure of 
bacteria to neopterin and chloramine-T drastically re- 
duces the number of colonies as compared to treatment 
with chloramine-T alone. On the other hand, concomi- 
tant administration of 7,8_dihydroneopterin and chlo- 
ramine-T to E. coli enhanced survival of bacteria as 
compared to chloramine-T control. This suggests that 
oxidized neopterin is a potent enhancer and multiplier 
of cytotoxic effects of hydrogen peroxide and chloram- 
ine-T, while 7,8_dihydroneopterin is a potent scavenger. 
The results were almost the same when using Staph. 
aureus for testing of toxicity, demonstrating that effects 
of neopterin and 7,8_dihydroneopterin on chloramine-T 
mediated cytotoxicity are not specific for E. co/i (details 
not shown). In contrast, bacterial growth was not 
altered after sole addition of 7,8_dihydroneopterin or 
neopterin (200 ,uM final concentration) to E. coli as 
compared with a control (bacteria supplemented with 
phosphate-buffered saline; details not shown). While 
the observation of scavenger activity for reduced pterid- 
ines is in good accordance with previously published 
reports [17,18], the potentiating effect of oxidized neop- 
terin and its pH dependence have not been described 
hitherto. Since neopterin and 7,8_dihydroneopterin are 
concomitantly synthesized with hydrogen peroxide by 
interferon-y stimulated macrophages [ 191, our observa- 
tions suggest that neopterin/dihydroneopterin modulate 
macrophage induced cytotoxicity either way. The ratio 
of neopterin to 7,8_dihydroneopterin may determine 
whether hydrogen peroxide or hypochlorous acid in- 
duced effects are potentiated or reduced. From our 
data, it is tempting to speculate that macrophages in- 
crease extracellular cytotoxicity by enhanced genera- 
tion. release and oxidation of 7,8_dihydroneopterin to 
form neopterin while they protect themselves from 
being damaged by intracellular accumulation of 7,8- 
dihydroneopterin. In a variety of clinical conditions ac- 
tivated macrophages and their secretory products con- 
tribute to tissue damage. This is most evident in patients 
with autoimmune disorders, allograft rejection, but also 
during infection. In all these clinical conditions in- 
creased neopterin levels have been found to correlate 
with the severity of the disease. Our findings suggest a 
potential role of neopterin in modulating macrophage- 
induced extracellular toxicity in dependence of pH and 
the relative ratio of neopterin to 7,8-dihydroneopterin. 
Our data may explain why activated macrophages pro- 
duce large amounts of neopterin, namely, to further 
enhance their cytotoxic potential. 
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